FilingReader Intelligence

Mitsubishi Chemical to transfer pharma business in company split

March 31, 2025 at 09:01 AM UTCBy FilingReader AI

Mitsubishi Chemical Group Corporation (TSE:4188) announced the planned transfer of its consolidated subsidiary, Mitsubishi Tanabe Pharma Corporation (MTPC), to a special purpose company under the umbrella of K.K. BCJ-94, indirectly owned by an investment fund advised by Bain Capital Private Equity. The transfer will be executed through a company split, with Mitsubishi Chemical as the splitting company and K.K. BCJ-94 as the successor.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Mitsubishi Chemical Holdings Corporation publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →